PHARMACEUTICS AND LIFE SCIENCE

Novo Nordisk Sues Lilly Over Misleading Weight-Loss Drug Ads in $150 Billion Market Battle

AusBiotech and Octopus Biotech Partner to Boost Drug Discovery in Australia

FDA Approves Vera's Trutakna: First Dual-Target IgAN Therapy Sets Up Market Showdown with Novartis and Otsuka

PHARMACEUTICS AND LIFE SCIENCE TOP NEWS

New National Program Targets Harmful Medicine Use: $5 Million Initiative to Help GPs and Pharmacists Safely Stop Unnecessary Prescriptions

AstraZeneca’s Bladder Cancer Immunotherapy Imfinzi Approval

Bladder Cancer Immunotherapy: AstraZeneca’s Imfinzi Gets 2nd FDA Nod

How Does RTSM Improve Clinical Trial Management

PHARMACEUTICS AND LIFE SCIENCE NEWS

Lilly Flourishes in Q4 as Peer Projections Signal Loomi..

Eli Lilly capped 2025 with 45% revenue growth to $65.2B, driven by Mounjaro and Zepbound. But sector-wide data shows cooling optimism, with only 72% o...

Novo Nordisk Partners with Vivtex in Up to $2.1B Oral O..

Novo Nordisk partnered with MIT spinout Vivtex in a deal worth up to $2.1 billion to develop next-generation oral biologic drugs for obesity and diabe...

Pharma Firms Left Out of Trump Drug Deals Seek Entry..

Drugmakers excluded from the Trump administration’s latest drug-pricing agreements are lobbying for inclusion, fearing competitive disadvantage ...

HHS Resets National Autism Panel with 21 New Members..

HHS Secretary Kennedy has appointed 21 new members to the Interagency Autism Coordinating Committee, resetting federal research and services policy. ...

AbbVie Plans Major Buildout in Competitive Obesity Drug..

Pharmaceutical giant AbbVie announces strategic plans to expand its presence and pipeline in the high-stakes, fast-growing market for obesity medicati...